172 related articles for article (PubMed ID: 18760436)
1. The vaccinia virus fusion inhibitor proteins SPI-3 (K2) and HA (A56) expressed by infected cells reduce the entry of superinfecting virus.
Turner PC; Moyer RW
Virology; 2008 Oct; 380(2):226-33. PubMed ID: 18760436
[TBL] [Abstract][Full Text] [Related]
2. Expression of the A56 and K2 proteins is sufficient to inhibit vaccinia virus entry and cell fusion.
Wagenaar TR; Moss B
J Virol; 2009 Feb; 83(4):1546-54. PubMed ID: 19036815
[TBL] [Abstract][Full Text] [Related]
3. Mutations Near the N Terminus of Vaccinia Virus G9 Protein Overcome Restrictions on Cell Entry and Syncytium Formation Imposed by the A56/K2 Fusion Regulatory Complex.
Cotter CA; Moss B
J Virol; 2020 May; 94(10):. PubMed ID: 32132239
[TBL] [Abstract][Full Text] [Related]
4. Experimental Evolution To Isolate Vaccinia Virus Adaptive G9 Mutants That Overcome Membrane Fusion Inhibition via the Vaccinia Virus A56/K2 Protein Complex.
Hong GC; Tsai CH; Chang W
J Virol; 2020 May; 94(10):. PubMed ID: 32132237
[TBL] [Abstract][Full Text] [Related]
5. A novel mode of poxvirus superinfection exclusion that prevents fusion of the lipid bilayers of viral and cellular membranes.
Laliberte JP; Moss B
J Virol; 2014 Sep; 88(17):9751-68. PubMed ID: 24920806
[TBL] [Abstract][Full Text] [Related]
6. Vaccinia virus A56/K2 fusion regulatory protein interacts with the A16 and G9 subunits of the entry fusion complex.
Wagenaar TR; Ojeda S; Moss B
J Virol; 2008 Jun; 82(11):5153-60. PubMed ID: 18353946
[TBL] [Abstract][Full Text] [Related]
7. Association of vaccinia virus fusion regulatory proteins with the multicomponent entry/fusion complex.
Wagenaar TR; Moss B
J Virol; 2007 Jun; 81(12):6286-93. PubMed ID: 17409143
[TBL] [Abstract][Full Text] [Related]
8. The vaccinia virus A56 protein: a multifunctional transmembrane glycoprotein that anchors two secreted viral proteins.
DeHaven BC; Gupta K; Isaacs SN
J Gen Virol; 2011 Sep; 92(Pt 9):1971-1980. PubMed ID: 21715594
[TBL] [Abstract][Full Text] [Related]
9. Activation of caspases in pig kidney cells infected with wild-type and CrmA/SPI-2 mutants of cowpox and rabbitpox viruses.
Macen J; Takahashi A; Moon KB; Nathaniel R; Turner PC; Moyer RW
J Virol; 1998 May; 72(5):3524-33. PubMed ID: 9557631
[TBL] [Abstract][Full Text] [Related]
10. The vaccinia virus K2L gene encodes a serine protease inhibitor which inhibits cell-cell fusion.
Zhou J; Sun XY; Fernando GJ; Frazer IH
Virology; 1992 Aug; 189(2):678-86. PubMed ID: 1641985
[TBL] [Abstract][Full Text] [Related]
11. Identification of functional domains in the 14-kilodalton envelope protein (A27L) of vaccinia virus.
Vázquez MI; Esteban M
J Virol; 1999 Nov; 73(11):9098-109. PubMed ID: 10516016
[TBL] [Abstract][Full Text] [Related]
12. Protein B5 is required on extracellular enveloped vaccinia virus for repulsion of superinfecting virions.
Doceul V; Hollinshead M; Breiman A; Laval K; Smith GL
J Gen Virol; 2012 Sep; 93(Pt 9):1876-1886. PubMed ID: 22622330
[TBL] [Abstract][Full Text] [Related]
13. Vaccinia mature virus fusion regulator A26 protein binds to A16 and G9 proteins of the viral entry fusion complex and dissociates from mature virions at low pH.
Chang SJ; Shih AC; Tang YL; Chang W
J Virol; 2012 Apr; 86(7):3809-18. PubMed ID: 22278246
[TBL] [Abstract][Full Text] [Related]
14. Orthopoxvirus fusion inhibitor glycoprotein SPI-3 (open reading frame K2L) contains motifs characteristic of serine proteinase inhibitors that are not required for control of cell fusion.
Turner PC; Moyer RW
J Virol; 1995 Oct; 69(10):5978-87. PubMed ID: 7666502
[TBL] [Abstract][Full Text] [Related]
15. Vaccinia virus exhibits cell-type-dependent entry characteristics.
Whitbeck JC; Foo CH; Ponce de Leon M; Eisenberg RJ; Cohen GH
Virology; 2009 Mar; 385(2):383-91. PubMed ID: 19162290
[TBL] [Abstract][Full Text] [Related]
16. Amplification of polyadenylated nontranslated small RNA sequences (POLADS) during superinfection correlates with the inhibition of viral and cellular protein synthesis.
Bablanian R; Scribani S; Esteban M
Cell Mol Biol Res; 1993; 39(3):243-55. PubMed ID: 7507390
[TBL] [Abstract][Full Text] [Related]
17. An orthopoxvirus serpinlike gene controls the ability of infected cells to fuse.
Turner PC; Moyer RW
J Virol; 1992 Apr; 66(4):2076-85. PubMed ID: 1548753
[TBL] [Abstract][Full Text] [Related]
18. Replication-deficient vaccinia virus gene therpay vector: evaluation of exogenous gene expression mediated by PUV-inactivated virus in glioma cells.
Timiryasova TM; Chen B; Fodor I
J Gene Med; 2001; 3(5):468-77. PubMed ID: 11601760
[TBL] [Abstract][Full Text] [Related]
19. Vaccinia virus recombinants expressing either the measles virus fusion or hemagglutinin glycoprotein protect dogs against canine distemper virus challenge.
Taylor J; Pincus S; Tartaglia J; Richardson C; Alkhatib G; Briedis D; Appel M; Norton E; Paoletti E
J Virol; 1991 Aug; 65(8):4263-74. PubMed ID: 1830113
[TBL] [Abstract][Full Text] [Related]
20. Cell surface expression of the vaccinia virus complement control protein is mediated by interaction with the viral A56 protein and protects infected cells from complement attack.
Girgis NM; Dehaven BC; Fan X; Viner KM; Shamim M; Isaacs SN
J Virol; 2008 May; 82(9):4205-14. PubMed ID: 18287241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
